michigan semaglutide side effect lawyer GLP-1 Drug Injury Attorneys - Ozempic, Wegovy & Mounjaro Claims Ozempic Lawsuit: July 2026 Blindness

Patients should avoid IGF-1 LR3 without medical clearance if they have blood sugar problems, diabetes risk, cancer history, abnormal growth concerns, cardiovascular disease, kidney or liver issues, active illness, pregnancy, breastfeeding, or current prescription medication use

Research indicates that the combination of these peptides in laboratory settings might maximize IGF-1 and growth hormone pathway activation potentially leading to tissue development, compositional changes and overall physiological adaptations

Effects of glucose and insulin on glucokinase activity in rat hypothalamus

Additionally, GLP-1 therapies suppress glucagon, a hormone that normally elevates blood sugar, further enhancing glucose regulation

FeelGood's published Terms explicitly state that approval is not guaranteed